scispace - formally typeset
Search or ask a question
Institution

University of North Texas

EducationDenton, Texas, United States
About: University of North Texas is a education organization based out in Denton, Texas, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 11866 authors who have published 26984 publications receiving 705376 citations. The organization is also known as: Fight, North Texas & UNT.


Papers
More filters
Journal ArticleDOI
TL;DR: This review firstly introduces the metallic biomaterials, important surface properties, and then elaborates some strategies on achieving the bioinspired surface functionalization for metallic biommaterials.
Abstract: Metallic biomaterials are widely used for clinical applications because of their excellent mechanical properties and good durability. In order to provide essential biofunctionalities, surface functionalization is of particular interest and requirement in the development of high-performance metallic implants. Inspired by the functional surface of natural biological systems, many new designs and conceptions have recently emerged to create multifunctional surfaces with great potential for biomedical applications. This review firstly introduces the metallic biomaterials, important surface properties, and then elaborates some strategies on achieving the bioinspired surface functionalization for metallic biomaterials.

139 citations

Journal ArticleDOI
TL;DR: In this paper, a Direct Numerical Simulation (DNS) method was developed to solve the heat transfer equations for the computation of thermal convection in particulate flows, which makes use of a finite difference method in combination with the Immersed Boundary (IB) method for treating the particulate phase.

139 citations

Journal ArticleDOI
TL;DR: This work presents clinicians with the need to objectively compare and contrast these agents to allow more effective treatment of their patients.
Abstract: Summary Background The relatively recent introduction of biological agents to treat psoriasis presents clinicians with the need to objectively compare and contrast these agents to allow more effective treatment of their patients. Objectives To evaluate and compare the efficacy and safety of biological agents in the treatment of plaque psoriasis. Methods (i) Data sources: Four parallel systematic reviews conducted through July 2006, including peer-reviewed data and U.S. Food and Drug Administration (FDA) reports. (ii) Study selection: Randomized, controlled, double-blind, monotherapy trials of alefacept (n = 3), efalizumab (n = 5), etanercept (n = 4) and infliximab (n = 4); 16 studies comprising 7931 patients met inclusion criteria. (iii) Data extraction: Efficacy was measured by Psoriasis Area and Severity Index (PASI) 75 achievement after 10–14 weeks of treatment, using intention-to-treat analysis. Safety was evaluated by the incidence of one or more adverse event(s) (AEs) and serious adverse event(s) (SAEs) during 10–30 weeks of treatment. Results Pooled relative risk (RR) and number needed to treat (NNT) of PASI 75 achievement compared with placebo was computed using Mantel–Haenszel methods and the random effects model. All biological agents for psoriasis were efficacious (P < 0·001); however, there was a graded response for achievement of PASI 75: infliximab (RR = 17·40, NNT = 2), etanercept (RR = 11·73, NNT = 3), efalizumab (RR = 7·34, NNT = 4) and alefacept (RR = 3·70, NNT = 8). The risk of one or more AEs was evaluated by RR and number needed to harm (NNH). This was increased in the alefacept (RR = 1·09, P = 0·03, NNH = 15), efalizumab (RR = 1·15, P < 0·001, NNH = 9) and infliximab (RR = 1·18, P < 0·001, NNH = 9) groups compared with placebo. SAEs were increased in a sensitivity analysis of four efalizumab trials (n = 2443, RR = 1·92, P = 0·03, NNH = 60). Conclusions The decreasing rank order for pooled efficacy was infliximab, etanercept, efalizumab and alefacept when compared with placebo. Pooling safety data revealed a previously unreported increased risk of AEs for alefacept, efalizumab and infliximab.

139 citations

Journal ArticleDOI
TL;DR: Patients with borderline personality disorder had significantly greater odds of a previous bipolar misdiagnosis, but no specific borderline criterion was unique in predicting this outcome.

139 citations

Journal ArticleDOI
TL;DR: In this paper, the authors investigated water vapor condensation on a two-tier superhydrophobic surface in an environmental scanning electron microscope (ESEM) and in a customer-designed vapor chamber.
Abstract: We investigated water vapor condensation on a two-tier superhydrophobic surface in an environmental scanning electron microscope (ESEM) and in a customer-designed vapor chamber. We have observed continuous dropwise condensation (DWC) on the textured surface in ESEM. However, a film layer of condensate was formed on the multiscale texture in the vapor chamber. Due to the filmwise condensation, the condensation heat transfer coefficient of the superhydrophobic surface is lower than that of a flat hydrophobic surface especially under high heat flux situations. Our studies indicate that adaptive and prompt condensate droplet purging is the dominant factor for sustaining long-term DWC.

139 citations


Authors

Showing all 12053 results

NameH-indexPapersCitations
Steven N. Blair165879132929
Scott D. Solomon1371145103041
Richard A. Dixon12660371424
Thomas E. Mallouk12254952593
Hong-Cai Zhou11448966320
Qian Wang108214865557
Boris I. Yakobson10744345174
J. N. Reddy10692666940
David Spiegel10673346276
Charles A. Nelson10355740352
Robert J. Vallerand9830141840
Gerald R. Ferris9333229478
Michael H. Abraham8972637868
Jere H. Mitchell8833724386
Alan Needleman8637339180
Network Information
Related Institutions (5)
Arizona State University
109.6K papers, 4.4M citations

95% related

Pennsylvania State University
196.8K papers, 8.3M citations

94% related

University of Tennessee
87K papers, 2.8M citations

93% related

Michigan State University
137K papers, 5.6M citations

93% related

State University of New York System
78K papers, 2.9M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202390
2022300
20211,795
20201,769
20191,644
20181,484